RT Journal Article
SR Electronic
T1 Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001681
DO 10.1136/jitc-2020-001681
VO 8
IS 2
A1 Atkinson, Victoria
A1 Khattak, Adnan
A1 Haydon, Andrew
A1 Eastgate, Melissa
A1 Roy, Amitesh
A1 Prithviraj, Prashanth
A1 Mueller, Christian
A1 Brignone, Chrystelle
A1 Triebel, Frederic
YR 2020
UL http://jitc.bmj.com/content/8/2/e001681.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.